# 25P-NBOMe
*Source: https://en.wikipedia.org/wiki/25P-NBOMe*

25P-NBOMe (2C-P-NBOMe, NBOMe-2C-P) is a derivative of the phenethylamine 2C-P. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT2A receptor. 25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

## Use and effects

The dose range of 25P-NBOMe has been given as 0.1 to 1.5 mg sublingually, with a typical dose estimate of 0.6 mg.

## Toxicity and harm potential

### Neurotoxic and cardiotoxic actions

### Emergency treatment

## Interactions

## Pharmacology

### Pharmacodynamics

25P-NBOMe is a potent agonist of the serotonin 5-HT2 receptors, including the serotonin 5-HT2A receptor.

## History

25P-NBOMe was first described in the scientific literature by 2012.

## Society and culture

### Legal status

#### United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
